MedPath

Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19

Not Applicable
Conditions
Respiratory Disease
Effectiveness
Disease, Infectious
Safety Issues
Registration Number
NCT04326114
Lead Sponsor
Universidad Complutense de Madrid
Brief Summary

A randomized controlled clinical trial will be carried out using inspiratory and expiratory training devices on healthy subjects recruited in social networks and university environments. The aim will be to determine the effectiveness and safety in the prevention and severity of COVID-19 disease by a respiratory training with inspiratory and expiratory devices.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
240
Inclusion Criteria
  • Healthy subjects
Exclusion Criteria
  • Drugs
  • Surgery
  • Neurology diseases
  • Rheumatic diseases
  • Systemic diseases
  • Smokers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
COVID-19 disease diagnosisChange from Baseline COVID-19 disease diagnosis at 8 weeks

Dichotomous categorical variable measured by "yes" or "no" responses

Secondary Outcome Measures
NameTimeMethod
COVID-19 disease symptoms severityChange from Baseline COVID-19 disease symptoms severity at 8 weeks

Dichotomous categorical variable measured by "slight" or "severe" responses

Adverse effectsChange from Baseline adverse effects at 8 weeks

Polytomous categorical variable measured by adverse effects responses

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.